Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerPolicy UpdatesObstetrics/GynecologyAmbetter Nevada fetal surgery coverage update | Op…
    Ask Trek AI about this page
    ModifiedAmbetter NevadaPolicy CP.MP.129

    Fetal Surgery in Utero for Prenatally Diagnosed Malformations

    Customize your policy alerts

    Sign up for Ambetter Nevada Policy CP.MP.129 alerts

    Get alerted when Policy CP.MP.129 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity criteria, coding implications, and exclusions for in‑utero fetal surgery procedures for specific prenatally diagnosed fetal malformations for members of Ambetter Nevada (Centene-affiliated plans). Affects providers performing fetal interventions and those requesting authorization.

    Policy Summary
    PayerAmbetter Nevada
    PolicyFetal Surgery in Utero for Prenatally Diagnosed Malformations
    Policy CodePolicy CP.MP.129
    Change TypeMaterial revisions to criteria and coding
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization and note that repeat in‑utero fetal surgery procedures require secondary review by the plan.
    SourceLink
    POLICY UPDATE CHANGES

    Added 'D. Placement of a thoraco-amniotic shunt for pleural effusion with or without secondary fetal hydrops' to criteria set I.

    Criteria for myelomeningocele (I.G) updated to require confirmation of hindbrain herniation on fetal MRI and specified gestational age window 19 0/7 to 25 6/7 weeks and singleton pregnancy.

    Added FETO criteria for CDH: severe left-sided CDH, observed-to-expected lung-to-head ratio <25%, gestational age ≤ 30 weeks.

    Removed specific degree requirement for severe kyphosis and removed prior maternal BMI contraindication for myelomeningocele criteria.

    Added CPT code 59072 (fetal umbilical cord occlusion) to coding list.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    7Medically necessary indications listed
    19–25wMyelomeningocele GA window
    <25%o/e LHR threshold for FETO
    RepeatSecondary review required
    CentenePolicy owner

    Medically Necessary Indications and Coverage Guidance

    Medically Necessary Indications

    Covered when the specific indication AND the listed subcriteria are met

    I.A Sacrococcygeal teratoma (SCT)

    • Fetuses with high-risk SCT and hydrops developing at a gestational age earlier than appropriate for delivery and neonatal care (e.g., 28–32 weeks gestation)
    • Contraindications absent: Does not have any of the following contraindications: Type III or IV Altman-type tumors; severe placentomegaly; maternal cervical shortening.
    I.B Lower urinary tract obstruction: Lower urinary tract obstruction without multiple fetal anomalies or chromosomal abnormalities: urinary decompression via vesico-amniotic shunting.
    I.C CPAM and extralobar BPS: Congenital pulmonary airway malformation (CPAM) and extralobar bronchopulmonary sequestration (BPS) with high-risk tumors: resection of malformed pulmonary tissue, or placement of a thoraco-amniotic shunt.
    I.D Pleural effusion with/without hydrops: Placement of a thoraco-amniotic shunt for pleural effusion with or without secondary fetal hydrops.

    I.E Twin-twin transfusion syndrome (TTTS)

    • Option 1: Amnioreduction.
    • Option 2: Fetoscopic laser ablation, with or without amnioreduction, when pregnancy is between 16 and 26 weeks gestation.16–26 weeks
    I.F TRAP sequence: Twin-reversed-arterial-perfusion (TRAP) sequence: ablation of anastomotic vessels of the acardiac twin (e.g., laser or radiofrequency ablation).

    I.G Myelomeningocele repair

    • Singleton pregnancy.
    • Upper boundary of myelomeningocele located between T1 and S1.
    • Evidence of hindbrain herniation confirmed on fetal MRI.
    • Gestational age between 19 0/7 weeks and 25 6/7 weeks.19 0/7–25 6/7 weeks
    • Exclusions: None of the following are present: severe kyphosis; risk of preterm birth (e.g., short cervix or previous preterm birth); placental abruption; previous hysterotomy in the active uterine segment.

    I.H FETO for CDH

    • Severe left-sided congenital diaphragmatic hernia (CDH).
    • Severe pulmonary hypoplasia defined as an observed-to-expected lung-to-head ratio (o/e LHR) of less than 25%.o/e LHR <25%
    • Gestational age ≤ 30 weeks.≤30 weeks

    Open or endoscopic fetal surgery is not supported for a number of specific fetal conditions because current evidence and clinical guidance do not demonstrate benefit or acceptable risk profiles for those indications. Examples listed in the policy include surgery for heart block, procedures to relieve pulmonary valve or aortic obstruction, and interventions for tracheal atresia or stenosis. Other unsupported procedures explicitly named are repair of cleft lip and palate, in‑utero stem cell transplantation, in‑utero gene therapy, and the amnioexchange procedure for gastroschisis. These exclusions reflect the policy’s intent to limit in‑utero surgical interventions to indications with sufficient evidence and established clinical protocols.

    The policy states that current evidence does not support use of in utero fetal surgery for several listed indications. Specifically, fetal surgery is considered unsupported for surgery for heart block, pulmonary valve or aortic obstruction, tracheal atresia or stenosis, cleft lip and palate, in‑utero stem cell transplantation, in‑utero gene therapy, and amnioexchange for gastroschisis. This reflects the plan’s review of available literature and consensus that these procedures lack sufficient proven benefit to merit coverage as medically necessary.

    This clinical policy is provided as a medical necessity guide to assist in coverage decisions and administration of benefits; it is not a contract and does not guarantee payment or clinical outcomes. Coverage determinations remain subject to the member’s applicable coverage documents, including evidence of coverage, certificates, and contracts, as well as state and federal requirements and Health Plan‑level administrative policies. The Health Plan may change, amend, or withdraw this clinical policy at any time, and providers must confirm plan‑level prior authorization and other administrative requirements before proceeding with care.

    Referenced Procedure and Billing Codes

    Referenced CPT CodesCPT
    59001Amniocentesis; therapeutic amniotic fluid reduction (includes ultrasound guidance).
    59076Fetal shunt placement, including ultrasound guidance.
    59897Unlisted fetal invasive procedure, including ultrasound guidance, when performed.
    59072Fetal umbilical cord occlusion, including ultrasound guidance
    Referenced HCPCS S‑codesHCPCS
    S2401Repair, urinary tract obstruction in the fetus, procedure performed in utero.
    S2402Repair, congenital cystic adenomatoid malformation in the fetus, procedure performed in utero.
    S2403Repair, extralobar pulmonary sequestration in the fetus, procedure performed in utero.
    S2404Repair, myelomeningocele in the fetus, procedure performed in utero.
    S2405Repair of sacrococcygeal teratoma in the fetus, procedure performed in utero.
    S2409Repair congenital malformation of fetus, procedure performed in utero, not otherwise classified.
    S2411Fetoscopic laser therapy for treatment of twin-to-twin transfusion syndrome.
    Observed-to-expected lung-to-head ratio (o/e LHR)
    Observed-to-expected lung-to-head ratio (o/e LHR)<25%
    Use in FETO for severe left-sided CDHRequired threshold for severe pulmonary hypoplasia is o/e LHR <25%
    Gestational age relevanceo/e LHR threshold applied when gestational age is ≤30 weeks for FETO candidacy
    Gestational age for myelomeningocele repair
    Myelomeningocele repair gestational age window19 0/7 to 25 6/7 weeks
    Singleton pregnancy requirementProcedure criteria require singleton pregnancy in addition to GA window

    Authorization, Documentation, and Claims Guidance

    Prior Authorization

    Prior Authorization and Secondary Review

    Prior authorization is required for in-utero fetal surgery procedures. Providers must obtain plan-level authorization prior to scheduling or performing these services. Repeat in-utero fetal surgery procedures require secondary review by the Health Plan before authorization will be considered.

    • Repeat procedures require secondary review
    • Obtain prior authorization before scheduling
    Prior Authorization

    Prior Authorization and Medical Necessity

    This clinical policy is a guide to medical necessity and does not itself guarantee coverage. Providers must confirm specific plan-level prior authorization requirements and benefit coverage with the member's Health Plan prior to providing services.

    • Policy provides medical necessity criteria but is not a guarantee of payment
    • Verify member benefits and authorization requirements with the Health Plan

    Background on Maternal-Fetal Surgery

    Maternal‑fetal surgery encompasses both open fetal surgery and fetoscopic (minimally invasive) approaches, and these interventions carry significant maternal and fetal risks. They are generally performed at specialized fetal therapy centers with multidisciplinary teams because procedures can increase the risk of maternal morbidity and frequently result in prematurity or other neonatal complications. Indications for intervention vary by anomaly and gestational age; for some conditions (for example, severe congenital diaphragmatic hernia or myelomeningocele) specific imaging findings and gestational age windows are required to consider intervention. Given the complexity and evolving evidence base, repeat procedures require secondary review and the policy emphasizes that only interventions supported by sufficient evidence and clear criteria are considered medically necessary.

    Procedural Definitions

    Open fetal surgery
    DefinitionOpen fetal surgery involves performing a hysterotomy, partially exteriorizing the fetus to expose and correct the abnormality, then returning the fetus to the uterus to continue development until delivery.
    Indication severityConsidered when the fetal condition is life threatening and the intervention is felt to be the only option for fetal survival.
    Setting requirementShould be offered only at facilities with specialized expertise, multidisciplinary teams, and intensive care capabilities.
    Fetoscopic (minimally invasive) fetal surgery
    DefinitionFetoscopic (minimally invasive) fetal surgery uses small fiberoptic telescopes and instruments introduced through small uterine openings to correct congenital malformations without major incisions or removing the fetus from the womb.
    Clinical advantage
    Policy Summary
    PayerAmbetter Nevada
    PolicyFetal Surgery in Utero for Prenatally Diagnosed Malformations
    Policy CodePolicy CP.MP.129
    Change TypeMaterial revisions to criteria and coding
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization and note that repeat in‑utero fetal surgery procedures require secondary review by the plan.
    SourceLink
    On This Page
    Medically Necessary Indications and Coverage GuidanceReferenced Procedure and Billing CodesAuthorization, Documentation, and Claims GuidanceBackground on Maternal-Fetal SurgeryProcedural Definitions
    MRI confirmation requiredEvidence of hindbrain herniation must be confirmed on fetal MRI for eligibility
    Denial Risk

    Denial Risk for Criteria Noncompliance

    Procedures that do not meet the listed medical necessity criteria are subject to denial. Ensure all required criteria are documented and met before submitting an authorization or claim to reduce the risk of claim denial.

    • Noncompliance with criteria places the request at high risk for denial
    • Confirm all eligibility and medical necessity criteria are satisfied
    Denial Risk

    Coverage and Denial Risk Reminder

    Coverage decisions are subject to all terms, conditions, exclusions, and limitations of the member's coverage documents and to applicable state and federal requirements. This clinical policy does not supersede contract language or state Medicaid and Medicare rules where they apply.

    • Coverage subject to evidence of coverage, policy, contract, and legal requirements
    • State Medicaid provisions supersede when in conflict with this policy
    • Review applicable NCDs, LCDs, and Medicare Coverage Articles for Medicare members
    Documentation Required

    Claims and Documentation Guidance

    Providers submitting claims and requests for prior authorization are bound by the terms of this clinical policy, the member's contract, and applicable state and federal rules. Maintain and submit required clinical documentation to support medical necessity at the time of authorization and upon request during claim adjudication.

    • Providers must retain and provide documentation supporting medical necessity
    • For Medicaid members, state Medicaid provisions take precedence when conflicting
    • For Medicare members, review NCDs/LCDs prior to applying policy criteria
    Documentation Required

    Required Clinical Documentation

    Required clinical documentation to establish medical necessity includes, but is not limited to: confirmation of hindbrain herniation on fetal MRI for myelomeningocele repair; documentation of gestational age; imaging and diagnostic reports supporting the specific indication (e.g., lung-to-head ratio for CDH, evidence of hydrops for SCT); and any other records demonstrating that all policy criteria are met.

    • Fetal MRI confirmation of hindbrain herniation when applicable
    • Gestational age documentation
    • Imaging/diagnostic reports (e.g., observed-to-expected lung-to-head ratio, evidence of hydrops)
    • Operative notes, prenatal consult notes, and maternal/fetal risk assessments as applicable
    Less traumatic than open surgery, reduces chances of preterm labor, and allows the fetus to remain in utero until more mature for delivery and neonatal procedures.
    Technique noteEmploys minimally invasive techniques rather than a hysterotomy and partial exteriorization of the fetus.